Financials data is unavailable for this security.
View more
Year on year Genky DrugStores Co Ltd grew revenues 9.35% from 169.06bn to 184.86bn while net income improved 32.74% from 4.77bn to 6.33bn.
| Gross margin | 20.41% |
|---|---|
| Net profit margin | 3.44% |
| Operating margin | 4.69% |
| Return on assets | 5.76% |
|---|---|
| Return on equity | 14.36% |
| Return on investment | 8.65% |
More ▼
Cash flow in JPYView more
In 2024, Genky DrugStores Co Ltd increased its cash reserves by 10.64%, or 567.00m. The company earned 13.26bn from its operations for a Cash Flow Margin of 7.17%. In addition the company used 10.63bn on investing activities and also paid 2.06bn in financing cash flows.
| Cash flow per share | 399.87 |
|---|---|
| Price/Cash flow per share | 7.82 |
| Book value per share | 1,582.20 |
|---|---|
| Tangible book value per share | 1,570.32 |
More ▼
Balance sheet in JPYView more
| Current ratio | 1.03 |
|---|---|
| Quick ratio | 0.4102 |
| Total debt/total equity | 0.7228 |
|---|---|
| Total debt/total capital | 0.4195 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 2.00% and 32.63%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Retail (Drugs) industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 0.63% |
|---|---|
| Div growth rate (5 year) | 0.40% |
| Payout ratio (TTM) | 5.97% |
| EPS growth(5 years) | 18.94 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 26.47 |
More ▼
